Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors.

Zhang X, Lowry JL, Brovkovych V, Skidgel RA.

Cell Signal. 2012 Aug;24(8):1619-31. doi: 10.1016/j.cellsig.2012.04.002. Epub 2012 Apr 12.

2.

Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling.

Zhang X, Brovkovych V, Zhang Y, Tan F, Skidgel RA.

Cell Signal. 2015 Jan;27(1):90-103. doi: 10.1016/j.cellsig.2014.09.019. Epub 2014 Oct 5.

3.

Functional and molecular characterization of kinin B1 and B 2 receptors in human bladder cancer: implication of the PI3Kγ pathway.

Sgnaolin V, Pereira TC, Bogo MR, Zanin R, Battastini AM, Morrone FB, Campos MM.

Invest New Drugs. 2013 Aug;31(4):812-22. doi: 10.1007/s10637-012-9907-6. Epub 2012 Dec 7.

PMID:
23224295
5.
6.

Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient b1 signaling from B2 agonists.

Zhang X, Tan F, Zhang Y, Skidgel RA.

J Biol Chem. 2008 Mar 21;283(12):7994-8004. doi: 10.1074/jbc.M709837200. Epub 2008 Jan 10.

7.
8.

Kinin-stimulated B1 receptor signaling depends on receptor endocytosis whereas B2 receptor signaling does not.

Enquist J, Sandén C, Skröder C, Mathis SA, Leeb-Lundberg LM.

Neurochem Res. 2014 Jun;39(6):1037-47. doi: 10.1007/s11064-013-1126-9. Epub 2013 Aug 10.

PMID:
23934212
9.

Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration.

Bertram CM, Baltic S, Misso NL, Bhoola KD, Foster PS, Thompson PJ, Fogel-Petrovic M.

J Leukoc Biol. 2007 Jun;81(6):1445-54. Epub 2007 Feb 27.

PMID:
17327486
10.

Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.

Meini S, Lecci A, Cucchi P, Catalioto RM, Criscuoli M, Maggi CA.

J Pharmacol Exp Ther. 1998 Oct;287(1):137-43.

11.

Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.

Santos EL, de Picoli Souza K, Cibrián-Uhalte E, Oliveira SM, Bader M, Costa-Neto CM, Oliveira L, Pesquero JB.

Int Immunopharmacol. 2008 Feb;8(2):282-8. doi: 10.1016/j.intimp.2007.09.007. Epub 2007 Oct 4.

PMID:
18182241
12.

Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron.

Zaika O, Mamenko M, O'Neil RG, Pochynyuk O.

Am J Physiol Renal Physiol. 2011 May;300(5):F1105-15. doi: 10.1152/ajprenal.00606.2010. Epub 2011 Feb 16.

13.

Involvement of prostaglandin E(2) derived from enteric glial cells in the action of bradykinin in cultured rat myenteric neurons.

Murakami M, Ohta T, Otsuguro KI, Ito S.

Neuroscience. 2007 Mar 16;145(2):642-53. Epub 2007 Feb 1.

PMID:
17275193
14.

Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.

MacNeil T, Feighner S, Hreniuk DL, Hess JF, Van der Ploeg LH.

Can J Physiol Pharmacol. 1997 Jun;75(6):735-40.

PMID:
9276157
15.
16.

Characterization of a novel proinflammatory effect mediated by BK and the kinin B₂ receptor in human preadipocytes.

Catalioto RM, Valenti C, Liverani L, Giuliani S, Maggi CA.

Biochem Pharmacol. 2013 Aug 15;86(4):508-20. doi: 10.1016/j.bcp.2013.06.005. Epub 2013 Jun 21.

PMID:
23796753
17.

Mechanisms involved in kinin-induced glioma cells proliferation: the role of ERK1/2 and PI3K/Akt pathways.

Nicoletti NF, Erig TC, Zanin RF, Pereira TC, Bogo MR, Campos MM, Morrone FB.

J Neurooncol. 2014 Nov;120(2):235-44. doi: 10.1007/s11060-014-1549-4. Epub 2014 Jul 24.

PMID:
25056222
18.

Kinin B1 and B2 receptor expression in osteoblasts and fibroblasts is enhanced by interleukin-1 and tumour necrosis factor-alpha. Effects dependent on activation of NF-kappaB and MAP kinases.

Brechter AB, Persson E, Lundgren I, Lerner UH.

Bone. 2008 Jul;43(1):72-83. doi: 10.1016/j.bone.2008.02.003. Epub 2008 Mar 10.

PMID:
18467203
19.
20.

Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists.

Martins AH, Alves JM, Perez D, Carrasco M, Torres-Rivera W, Eterović VA, Ferchmin PA, Ulrich H.

PLoS One. 2012;7(2):e30755. doi: 10.1371/journal.pone.0030755. Epub 2012 Feb 10.

Supplemental Content

Support Center